KNSA

Kiniksa Pharmaceuticals International (KNSA)

About Kiniksa Pharmaceuticals International (KNSA)

Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.

Details

Daily high

$41.99

Daily low

$41.18

Price at open

$41.65

52 Week High

$42.98

52 Week Low

$17.82

Market cap

3.2B

Dividend yield

0.00%

Volume

619,402

Avg. volume

360,102

P/E ratio

92.75

Kiniksa Pharmaceuticals International News